期刊文献+

甲状腺微小癌的热消融治疗 被引量:2

Thermal ablation of thyroid microcarcinoma
原文传递
导出
摘要 甲状腺微小癌包括各种亚型的甲状腺癌,但主要指甲状腺微小乳头状癌(PTMC),其发病率增长迅速但复发率和死亡率均无明显增加。热消融作为近年来发展迅速的新技术,包括激光消融、射频消融及微波消融。国内已有多个研究者尝试将其用于PTMC的一线治疗,具有一定的有效性和安全性。虽然目前已有一些指南和共识提出了热消融的指征,但最佳的适应证、术前评估肿瘤和淋巴结情况、合理的术后管理等,仍是热消融用于PTMC一线治疗需要面临的巨大挑战。 Thyroid microcarcinoma,including various subtypes of thyroid cancer,mainly refers to thyroid papillary microcarcinoma(PTMC).The incidence of PTMC has raised rapidly,but the recurrence and the mortality had no significant increase.As a new technique developed rapidly in recent years,thermal ablation,including laser ablation,radiofrequency ablation and microwave ablation,has been attempted as the first-line treatment of PTMC due to its good efficacy and safety.Although some indications of thermal ablation have suggested by a few of guidelines and consensus,appropriate indications,preoperative evaluation of tumor and lymph glands and suitable postoperative management have still been challenging for thermal ablation used in the first-line treatment of PTMC.
作者 陈茉 徐书杭 刘超 Chen Mo;Xu Shuhang;Liu Chao(Department of Endocrinology,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Province Academy of Traditional Chinese Medicine,Nanjing 210028,China)
出处 《国际内分泌代谢杂志》 2019年第6期405-408,418,F0003,共6页 International Journal of Endocrinology and Metabolism
基金 江苏省“六大人才高峰”项目(2013-WSN-063) 江苏省临床医学科技专项-重点病种的规范化诊疗(BL2013040) 江苏省医院协会医院管理创新研究课题(JSYGY-1-2018-301)。
关键词 甲状腺微小癌 甲状腺微小乳头状癌 热消融 Thyroid microcarcinoma Thyroid papillary microcarcinoma Thermal ablation
  • 相关文献

参考文献4

二级参考文献70

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献553

同被引文献24

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部